Bay Street News - Page 1284 of 13672

TSX News - July 31, 2024

Aberdeen Announces the Appointment of Fred Leigh as Chief Executive Officer and Other Updates

TORONTO, July 31, 2024 (GLOBE NEWSWIRE) — ABERDEEN INTERNATIONAL INC. (“Aberdeen” or the “Company”) (TSX: AAB, F:A8H, OTC:AABVF) is pleased to […]

NYSE Companies - July 31, 2024

Emergent BioSolutions Completes Sale of RSDL® (Reactive Skin Decontamination Lotion) Kit to SERB Pharmaceuticals for $75 Million

GAITHERSBURG, Md., July 31, 2024 (GLOBE NEWSWIRE) — Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the sale of RSDL® (Reactive Skin Decontamination […]

NYSE Companies - July 31, 2024

Le Plan de transport des céréales 2024-2025 du CN s’appuie sur une performance solide

MONTRÉAL, 31 juill. 2024 (GLOBE NEWSWIRE) — Le CN (TSX: CNR) (NYSE: CNI) a publié aujourd’hui son Plan de transport […]

NYSE Companies - July 31, 2024

2024-2025 CN Grain Plan Builds on Strong Performance

MONTREAL, July 31, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today published its 2024-2025 Grain Plan, which builds […]

TSX News - July 31, 2024

CEMATRIX To Report Second Quarter Results On August 7, 2024

CALGARY, Alberta, July 31, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a North […]

Canadian Stock Exchange News - July 31, 2024

Repeat: Treatment.com AI announces AI Pharmacy Assistant

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or […]

NYSE Companies - July 31, 2024

Diana Shipping Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024; Declares Cash Dividend of $0.075 Per Common Share for the Second Quarter 2024

ATHENS, Greece, July 31, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing […]

NYSE Companies - July 31, 2024

Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma

ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) — Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics […]